Zobrazeno 1 - 10
of 22
pro vyhledávání: '"R, Gammans"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
R. Gammans, U. Schwiderski, John F. Dashe, P. Pullicino, David M. Lefkowitz, L. Sabounjian, L. Creed Pettigrew, Steve Warach, K. Harnett
Publikováno v:
Annals of Neurology. 48:713-722
We examined the effect of the neuroprotective and neuroreparative agent citicoline on the growth of cerebral ischemic lesions in a double-blind placebo-controlled study involving patients with acute ischemic stroke using diffusion-weighted magnetic r
Autor:
Douglas S. Greene, Rashmi H. Barbhaiya, Kenneth A. Pittman, Punit Marathe, Richard R. Gammans, Robert F. Mayol, Donald S. Robinson, U A Shukla
Publikováno v:
The Journal of Clinical Pharmacology. 35:974-984
Safety, tolerance, and preliminary pharmacokinetics of nefazodone, a new antidepressant, were assessed in a randomized, double-blind, parallel group study carried out in two sequential segments : a single and a multiple daily dose segment. Nine subje
Autor:
S, Warach, L C, Pettigrew, J F, Dashe, P, Pullicino, D M, Lefkowitz, L, Sabounjian, K, Harnett, U, Schwiderski, R, Gammans
Publikováno v:
Annals of neurology. 48(5)
We examined the effect of the neuroprotective and neuroreparative agent citicoline on the growth of cerebral ischemic lesions in a double-blind placebo-controlled study involving patients with acute ischemic stroke using diffusion-weighted magnetic r
Autor:
P J, Blanchet, J, Fang, M, Gillespie, L, Sabounjian, K W, Locke, R, Gammans, M M, Mouradian, T N, Chase
Publikováno v:
Clinical neuropharmacology. 21(6)
The contribution of dopamine D1 receptor stimulation to the motor effects of dopaminergic drugs in patients with Parkinson's disease remains undetermined. The authors of this article studied the clinical efficacy, pharmacokinetics, and tolerability o
Autor:
K. Locke, R. Gammans, M. Cooney, Anthony W. Tolcher, M. Munsey, J. Sarantopoulos, Joanna M. Brell, A. Ricart, S. Remick
Publikováno v:
European Journal of Cancer Supplements. 4:111-112
Publikováno v:
European Journal of Cancer Supplements. 5:135
Autor:
G. Medina, John Sarantopoulos, R. Gammans, Anthony W. Tolcher, Scot C. Remick, Matthew M. Cooney, A. Ricart, K. Locke, Joanna M. Brell, A. Zambito
Publikováno v:
Journal of Clinical Oncology. 24:3096-3096
3096 Background: MN-029 is a novel VDA that binds reversibly to the colchicine-binding site on tubulin and inhibits microtubule assembly, resulting in disruption of the cytoskeleton of tumor endothelial cells (EC). Disruption of the tumor EC cytoskel
Publikováno v:
European Journal of Cancer. 37:S361
Publikováno v:
European Neuropsychopharmacology. 3:423